3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Wound Infection
1
Urinary Tract Infections
1
Stomatitis
1
Sepsis
1
Prostatic Neoplasms
1
Pleural Effusion, Malignant
1
Head and Neck Neoplasms
1
Fever
1
Esophageal Neoplasms
1
Breast Neoplasms
1
Interventions
Fibroblast Growth Factor 7
9
avasopasem manganese
4
Low-Level Light Therapy
4
Cisplatin
4
Mouthwashes
3
Control Groups
3
Water
2
Standard of Care
2
Sodium Chloride
2
Sodium Bicarbonate
2
Radiotherapy, Intensity-Modulated
2
Radiotherapy
2
Propolis
2
Laser Therapy
2
Injections
2
FGF20 protein, human
2
Drug Therapy
2
Chlorhexidine
2
Benzydamine
2
Ascorbic Acid
2
whole grape extract
1
sargramostim
1
samital
1
peppermint oil
1
oxycodone-acetaminophen
1
meclocycline
1
golotimod
1
dusquetide
1
calcium phosphate
1
brilacidin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Stomatitis
×
Povidone-Iodine
×
Clear all
NCT00845819
2015-01-21
EGFOM
Seoul National University Hospital
Phase 2
Completed
138 enrolled